TROG Annual Research Report
The TROG
2012 Annual Research Report is now available.
Upcoming Meetings
- Elekta 2013 Users Meeting; Melbourne 16-18th August 2013.
The Elekta Australasian User Meeting is being held at the Sofitel on Collins, Melbourne from
16th to 18th of August. Further details can be found at their website. \
Elekta & The Austin are pleased to announce that submission of Abstracts for the meeting is open.
Elekta also announces that the annual $5,000 Elekta Award for Best Paper will be presented again
at the 2013 User Meeting.
For further details on submission & requirements please contact Suzi Bryce at au.events@elekta.com
- European Cancer Congress will be held in Amsterdam 27/09 to 1/10 2013.
have any late breaking data to submit.
- Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting; Melbourne 8-10th October 2013.
The AGITG ASM is being held at the Sofitel Melbourne in conjunction with the Australian Gastroinstestinal
Week at Melbourne Convention Center from 8 -10 October 2013.
Poster and New Concepts submissions close 26 August 2013.
- Global Controversies and Advances in Skin Cancer held in Brisbane 21-24th November 2013.
Please see the Global Controversies and Advances in Skin Cancer
flyer for more information.
Abstracts submissions close 07 June 2013.
To register your interest and to view the preliminary program please go to
www.gc-sc.org
TROG Cancer Research - 26th Annual Scientific Meeting
Twin Waters Resort, Sunshine Coast, QLD
1st-4th April, 2014
Convenor: Bryan Burmeister
Cancer Institute NSW HREC Announcement
There has been a recent decision by the Cancer Institute NSW to transition its Clincal Research Ethics Committee to local ethics operations. Over the next 6-8 months the Cancer Institute NSW will facilitate transition arrangements for current projects overseen by the committee. They will contact chief investigators with open studies regarding arrangements for the ongoing ethical oversight of their projects. Until this transition trials will continue to have current ethical approval. Investigators will receive correspondence about the transition arrangements over the next month.